BioNTech says Sobi's Oelkers will replace Sahin as CEO

German biotech ​firm BioNTech said ‌on Monday that Sobi's CEO Guido Oelkers will ​succeed Ugur ​Sahin as its chief executive.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。